{"id":12127,"date":"2025-03-13T21:19:21","date_gmt":"2025-03-13T20:19:21","guid":{"rendered":"https:\/\/valintermed.com\/?p=12127"},"modified":"2025-03-13T21:19:21","modified_gmt":"2025-03-13T20:19:21","slug":"multisistemnyy-vospalitelnyy-sindrom-u-detey-mis-c","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/multisystem-inflammatory-syndrome-in-children-with\/","title":{"rendered":"Multisystem inflammatory syndrome in children (MIS-C)"},"content":{"rendered":"
<\/div>\n

Multisystem inflammatory syndrome in children (MIS-C) is a rare but potentially serious condition that occurs in children and adolescents after COVID-19 infection. The specific clinical picture is determined by significant inflammation affecting multiple body systems, including the cardiovascular, gastrointestinal, and immune systems. MIS-C is often characterized by high fever, abdominal pain, skin rashes, and cardiac and other organ dysfunction. Importantly, this syndrome can develop even several weeks after the acute phase of COVID-19, making it particularly difficult to diagnose and manage. A comprehensive approach to diagnosing and treating MIS-C involves a multidisciplinary team of healthcare professionals and often requires hospitalization.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n